British physician and microbiologist Alexander Fleming, discoverer of penicillin nearly 100 years ago, was the first to warn ...

By analyzing E. coli protein levels, scientists found a surplus of membrane shuttle proteins that may play a role in ...

Following Pope Francis’ diagnosis of bilateral pneumonia, respiratory doctors are speaking about the condition. The Vatican ...

Infex Therapeutics, the Alderley Park-based anti-infectives specialist, has been awarded a £1m grant, alongside Germany’s ...

A Cornell University-led collaboration has uncovered the equipment that enables bacteria to survive exposure to antibiotics: ...

Cornell researchers have identified a key protein mechanism that helps bacteria expel antibiotics, making them more resistant ...

STOCKHOLM, SWEDEN, February 18 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Promimic has published positive results showing a reduction of ...

Research into developing new antimicrobial resistance treatment in Nigeria and other low/middle-income countries has fuelled ...

AbbVie has announced that the US Food and Drug Administration (FDA) has approved its Pfizer-partnered Emblaveo ...

Research into developing new antimicrobial resistance treatments in Nigeria and other low/middle-income countries has secured ...

AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI) ...